Myongji Hospital
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 1982-01-18
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.kdmc.or.kr
Clinical Trials
26
Active:3
Completed:9
Trial Phases
1 Phases
Not Applicable:26
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (26 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
26 (100.0%)CABG Based on CT-FFR Versus Conventional Coronary Angiography
Not Applicable
Recruiting
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2023-09-08
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Myongji Hospital
- Target Recruit Count
- 96
- Registration Number
- NCT06028165
- Locations
- π°π·
Myongji Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of
Transumbilical Laparoscopy-assisted Appendectomy
Not Applicable
- Conditions
- Appendicitis Acute
- First Posted Date
- 2020-07-24
- Last Posted Date
- 2020-09-02
- Lead Sponsor
- Myongji Hospital
- Target Recruit Count
- 78
- Registration Number
- NCT04485247
- Locations
- π°π·
Myongji Hospital, Hanyang university college of medicine, Goyang, Gyeonggi-do, Korea, Republic of
News
Myongji Hospital Develops AI-Powered Tool to Predict Ovarian Cancer Drug Resistance
A research team at Myongji Hospital has developed the Ovarian Cancer Assay, a diagnostic tool to predict chemotherapy resistance in ovarian cancer patients.